Magnetic Reactive Oxygen Species Nanoreactor for Switchable Magnetic Resonance Imaging Guided Cancer Therapy Based on Ph-Sensitive Fe5C2@Fe3O4 Nanoparticles.
Jing Yu,Fan Zhao,Weiliang Gao,Xue Yang,Yanmin Ju,Lingyun Zhao,Weisheng Guo,Jun Xie,Xing-jie Liang,Xinyong Tao,Juan Li,Yao Ying,Wangchang Li,Jingwu Zheng,Liang Qiao,Subin Xiong,Xiaozhou Mou,Shenglei Che,Yanglong Hou
DOI: https://doi.org/10.1021/acsnano.9b01740
IF: 17.1
2019-01-01
ACS Nano
Abstract:Reactive oxygen species (ROS) are crucial molecules in cancer therapy. Unfortunately, the therapeutic efficiency of ROS is unsatisfactory in clinic, primarily due to their rigorous produced condition. By taking advantage of intrinsic acidity and overproduction of H2O2 in the tumor environment, we have reported an ROS nanoreactor based on core-shell-structured iron carbide (Fe5C2@Fe3O4) nanoparticles (NPs), through the catalysis of Fenton reaction. These NPs are able to release ferrous ions in acidic environments to disproportionate H2O2 into •OH radicals, which effectively inhibits the proliferation of tumor cells both in vitro and in vivo. The high magnetization of Fe5C2@Fe3O4 NPs is favorable for both magnetic targeting and T2-weighted magnetic resonance imaging (MRI). Ionization of these NPs simultaneously decreases the T2 signal and enhances the T1 signal in MRI, and this T2/T1 switching process provides the visualization of ferrous ions release and ROS generation for the supervision of tumor curing. These Fe5C2@Fe3O4 NPs show great potential in endogenous environment-excited cancer therapy with high efficiency and tumor specificity, and can be guided further by MRI.